Edition:
United Kingdom

People: Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

8.96USD
13 Sep 2019
Change (% chg)

-- (--)
Prev Close
$8.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
224,013
52-wk High
$15.47
52-wk Low
$6.00

Lyons-Williams, Lori 

Ms. Lori Lyons-Williams is Chief Commercial Officer of the Company. She has served as our Chief Commercial Officer since December 2016. Prior to joining Dermira, Ms. Lyons-Williams served 15 years in various positions within the sales and marketing organization at Allergan plc, a pharmaceutical company, most recently as Vice President, Sales & Marketing for the Urology franchise from January 2014 to August 2016. In previous roles within Allergan, she served as Product Director for Allergan’s medical dermatology brands and also held senior-level positions on the Aczone and Botox marketing teams. Ms. Lyons-Williams began her career as a pharmaceutical sales representative at Johnson & Johnson. She currently serves as a director and Vice Chair of the National Association for Continence, a non-profit organization. She holds an M.B.A. from the Carlson School of Management of the University of Minnesota and a B.A. in interdisciplinary studies from Virginia Polytechnic Institute and State University.

Basic Compensation

Total Annual Compensation, USD 1,716,530
Restricted Stock Award, USD 875,098
Long-Term Incentive Plans, USD --
All Other, USD 113,000
Fiscal Year Total, USD 2,704,630

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Thomas Wiggans

4,371,180

Luis Pena

2,519,500

Andrew Guggenhime

2,360,030

Christopher Horan

2,358,110

Christopher Griffith

833,154

Lori Lyons-Williams

2,704,630
As Of  31 Dec 2018